Adsorption onto silica-based high surface area carriers is a long known method of improvement drug dissolution rate, which has been described in early 1970s [1]. Porous silica has many silanol groups on its surface and can be used as pharmaceutical excipient, since it is regarded nontoxic after oral application. Due to its porous structure and large specific surface area, porous silica has a great capacity to adsorb organic compounds into its nano-sized pores and can improve physical stability of amorphous drug [2]. Solid dispersions of carvedilol in porous silica (Sylysia 350) were prepared by solvent evaporation in a vacuum evaporator which ensures efficient pore filling procedure [3]. Two sets with different concentrations of carvedilol in solid dispersions were prepared, which differ in pore filling process. Set a) was prepared by one-step filling and set b) by multiple filling of smaller portions of dissolved carvedilol into porous silica. Solid dispersions were characterized by thermal analysis (DSC), X-ray diffraction and nitrogen adsoprtion experiments. Specific surface area and porosity parameters of solid dispersion samples confirm different mechanism of drug loading within silica pores in each experimental set. Results showed that carvedilol is more efficiently "packed" inside porous matrix when multiple drug filling procedure of smaller amounts is used as suggested by absence of crystalline state of a drug and greatly reduced porosity, while at the same time physical stability of amorphous carvedilol was most improved. Due to space restriction carvedilol can not crystallize when it is entrapped in a region of pores of smaller diameters than the minimum size of crystalline nucleus. Once the amorphous form of drug is stabilized inside porous silica it remains physically stable against crystallization and water sorption, while pure amorphous drug partially crystallized and adsorbed a detectable amount of moisture. The authors acknowledge to KRKA, d.d 
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